Infectious Diseases

Infectious Diseases

Manuscripts, Reports, and Posters

  • Systematic and structured literature reviews of the prevalence of dyslipidemia, lipids and cardiovascular events, lipid monitoring, effects of anti-retroviral regimens on lipid profiles, and management of dyslipidemia in patients with HIV-1
  • Systematic literature review on the neuropsychiatric safety, tolerability, toxicity, and discontinuation of integrase strand transfer inhibitors for the treatment of HIV-1
  • A retrospective, observational, multicenter study to characterize the incidence and identify nursing strategies for the prevention of nonventilator, hospital-acquired pneumonia for JAMA Internal Medicine
  • A phase 3, multinational, stratified, randomized, double-blind study of oral delafloxacin versus intravenous vancomycin plus aztreonam for acute bacterial skin and skin structure infections for Clinical Infectious Diseases
  • A phase 3, multinational, stratified, randomized, double-blind study of intravenous plus oral delafloxacin versus intravenous vancomycin plus aztreonam for acute bacterial skin and skin structure infections for Journal of Antimicrobial Chemotherapy
  • The incidence, risk factors, and economic burden of nonventilator hospital-acquired pneumonia in the United States for JAMA Internal Medicine
  • Risk factors for exposure to Legionella pneumophila among dental practitioners for Journal of the American Dental Association
  • A multicenter, phase 2, randomized, open-label, active comparator dose-finding study of oritavancin for subjects with S. aureus bacteremia for Diagnostic Microbiology and Infectious Disease
  • Oritavancin compared with vancomycin for gram-positive acute bacterial skin and skin structure infections for Antimicrobial Agents and Chemotherapy
  • Understanding the “true” hospital burden of paediatric respiratory syncytial virus in the United Kingdom for Acta Paediatrica
  • A multicenter, randomized, controlled study to evaluate carriage prevalence of N. meningitidis combined serogroups at 1 month following a single dose of MenACWY conjugate vaccine and carriage prevalence of virulent sequence types of N. meningitidis group B at 1 month following 2 doses of 4CMenB vaccine for Lancet
  • A randomized, single-blind, dose-range study to assess the immunogenicity and safety of a cell culture-derived A/H1N1 influenza vaccine in a pediatric population for Pediatrics
  • Evaluation of the safety of a conjugate meningococcal vaccine administered to healthy infants in conjunction with routine pediatric vaccinations for Vaccine
  • Five-year follow-up evaluation of the efficacy, safety, and histologic changes in hepatic function associated with tenofovir versus adefovir dipivoxil for chronic hepatitis B for New England Journal of Medicine
  • Comparison of the viral kinetics of two agents for chronic hepatitis B for Hepatology International
  • New directions in antimicrobial agents for Journal of Antimicrobial Chemotherapy
  • Evaluation of an intervention to improve nurses’ clinical decisions for management of sepsis for Intensive Care Medicine
  • Clinical management of sepsis for Critical Care Medicine
  • Pharmacokinetics of an anti-fungal agent for onychomycosis for Journal of Drugs in Dermatology
  • Assessing and managing neurocognitive disturbances in patients with HIV for MedPage Today
  • Poster on a phase 3, multinational, stratified, randomized, double-blind study of intravenous plus oral delafloxacin versus intravenous vancomycin plus aztreonam for acute bacterial skin and skin structure infections for IDWeek 2016
  • Poster on an evaluation of digital versus manual assessment of lesion size in a phase 3 trial of delafloxacin for acute bacterial skin and skin structure infections for IDWeek 2016
  • In vitro activity of delafloxacin and microbiological response against fluoroquinolone-susceptible and non-susceptible S. aureus isolates from 2 phase 3 studies of acute bacterial skin and skin structure infections for IDWeek 2016
  • Characteristics of patients hospitalized for acute bacterial skin and skin structure infections from 2009 to 2013 for IDWeek 2016
  • Poster on the pharmacokinetics of an antifungal agent for onychomycosis for the 2008 annual scientific meeting of the American Podiatric Medical Association


CME Programs, Training Programs, and Advisory Boards

  • E-learning program for clinical sales specialists and medical science liaisons on the diagnosis of nontuberculous mycobacterial lung infection
  • Disease backgrounder on the epidemiology, pathogenesis, risk factors, treatment and prognosis of pneumonia, urinary tract infections, pyogenic arthritis, osteomyelitis, endocarditis, and cellulitis in acutely ill, hospitalized patients
  • Evaluation of the incidence and risk factors, current treatment strategies, clinical outcomes, and healthcare utilization for Clostridium difficile diagnosed in residents of long-term care facilities
  • Educational program on the development and validation of a risk prediction model for recurrent Clostridium difficile
  • Educational program on risk factors for hospital-acquired versus community-acquired Clostridium difficile
  • Educational program on risk factors for rehospitalization among patients with recurrent Clostridium difficile
  • Educational program on the trends in health care resource utilization and among hospitalized patients with Clostridium difficile
  • Educational program on the clinical and economic burden of Clostridium difficile-associated diarrhea among high-risk populations during hospitalization
  • Educational program on health care resource utilization and the economic burden of Clostridium difficile-associated diarrhea among patient populations at high risk of recurrence following hospital discharge
  • Educational program on the epidemiology of HIV/AIDS and adherence to HIV/AIDS therapeutic regimens
  • Educational program on vancomycin resistance
  • Educational program on Staphylococcus aureus resistance to antibiotics
  • Web-based program on pharmacologic options for hepatitis B
  • Summary of the proceedings of an advisory board on diagnosis, treatment, and long-term management of primary immune deficiency disorder


CME Proposals

  • Changes in the epidemiologic burden, screening, and treatment for demographically diverse patient groups with HIV
  • Changes in the epidemiologic burden and treatment recommendations for HIV in women, children, and traditional high-risk populations
  • Current and emerging epidemiologic trends and pharmacological treatments for HIV
  • Current and emerging pharmacological treatments for HIV
  • Screening, diagnosis, and optimal management of hepatitis B
  • Current and new treatment regimens for relapsed or refractory hepatitis C
  • Treatment regimens tailored to meet the health, educational, and social needs of black, Hispanic, and female populations with HIV
  • Culturally appropriate interventions to promote adherence to HIV treatment regimens, including management of comorbid health conditions
  • Emerging issues for the management of fungal infections
  • Pharmacologic options for hepatitis B
  • Critical analysis of a continuing medical education grant proposal on hepatitis B and C


Return to Expertise page.